Skip to main content

Transmission of oral microbiota to the biliary tract during endoscopic retrograde cholangiography



Endoscopic retrograde cholangiography (ERC) possesses a translocation risk of microbes to the biliary system. We studied bile contamination during ERC and its impact on patients’ outcome in a real-life-situation.


Ninety-nine ERCs were analyzed and microbial samples were taken from the throat before and from bile during ERC and from irrigation fluid of the duodenoscope before and after ERC.


91.2% of cholangitis patients had detectable microbes in the bile (sensitivity 91%), but the same was true for 86.2% in the non-cholangitis group. Bacteroides fragilis (p=0.015) was significantly associated with cholangitis. In 41.7% of ERCs with contaminated endoscopes these microbes were found in the bile after the procedure. Analysis of duodenoscopes’ irrigation liquid after ERC matched the microbial bile analysis of these patients in 78.8%. Identical microbial species were in throat and in bile samples of the same ERC in 33% of all cases and in 45% in the non-cholangitis group. Transmission of microbes to the biliary tract did not result in more frequent cholangitis, longer hospital stays, or worse outcome.


During ERC bile samples are regularly contaminated with microbes of the oral cavity but it did not affect clinical outcome.

Peer Review reports


Distal biliary strictures (DBS) are common and may be caused by both malignant and benign pathologies [1]. Cholangitis is a frequent and potentially serious complication in patients with bile duct obstruction. Biliary decompression, one of the key elements of DBS and cholangitis treatment, is most often achieved by techniques applied at endoscopic retrograde cholangiography (ERC). Multiple studies support superior outcomes and decreased mortality rates with ERC compared to interventional radiology or surgical modalities [2,3,4].

At present, these highly beneficial ERC procedures are primarily performed using reusable duodenoscopes, but due to their complex architecture and design, duodenoscopes are difficult to clean [5, 6]. Insufficient cleaning results in remaining microbiological debris in patient-ready duodenoscopes, which might cause patient-to-patient cross-contamination and subsequent infections [7, 8]. Thus, there are controversies with regards to the impact of contaminated duodenoscopes, and whether such equipment can cause post-endoscopic device-related infections that could negatively affect patient safety [8].

ERC was always assumed to possess an inherent translocation risk of microbial species between the oral cavity and the biliary system. Additionally, endoscopic manipulations such as sphincterotomy or biliary stent insertion during ERC may increase the risk for translocation of microbes from the upper gastrointestinal tract into the bile by disrupting anatomical and functional barriers. Therefore, one complication of ERC that occurs in up to 0.5-3.0% is cholangitis, which can cause life threatening septicemia [9, 10].

The aim of the present study was to assess biliary contamination during the endoscopic procedure and consequently the validity of microbiological test results obtained from bile samples during ERCs. Therefore, known risk factors for cholangitis, biochemical indicators of cholangitis, microbiological samples from duodenoscopes before and after ERC, bile samples, and throat swabs were taken before and during ERC. Data were analyzed regarding the clinical diagnosis of cholangitis as defined by the Tokyo guidelines of 2018 [11].


Sample collection

This retrospective study comprises data from the hygiene surveillance program and includes 99 ERCs in the University Hospital of the Medical University of Innsbruck between November 2010 and October 2011. None of the patients received antibiotic therapy within 3 months before hospitalization for ERC. In 40 ERCs antibiotic therapy was administered within 24 hours before or during ERC. The antibiotic therapy included quinolones (n=16), β-Lactam antibiotics/β-Lactamase inhibitors (n=13), nitroimidazoles (n=8), or 3rd generation cephalosporines (n=3).

Each examination included two microbial samples coming from a throat swab taken before endoscopy and a bile sample taken during the examination. Additionally two microbial samples were taken from the duodenoscope: one before and one after ERC. For bile collection a bile specimen was collected after cannulation of the papilla by passing a sterile 5 French standard ERC- or balloon-catheter into the common bile duct and aspirating bile into a sterile 10 mL syringe (Injekt, B. Braun, Melsungen, Germany). 20 ml sterile-deionized water (B. Braun, Melsungen, Germany) were flushed through the duodenoscope immediately before and after ERC. Aqua bidest was collected into a sterile 20 mL syringe (Injekt, B. Braun, Melsungen, Germany).

Microbiological analysis and susceptibility testing

Bile aspirates and irrigation fluid were transported in sterile test tubes, aerobic or anaerobic culture bottles and throat swabs were transported in a sterile test tubes. Samples reached the laboratory within one hour for immediate processing. Bile samples and irrigation liquid of duodenoscopes were cultivated on Columbia blood agar, Bacteroides Bile Esculin (BBE) and Schaedler anaerobic agar (all Becton Dickinson, Heidelberg, Germany) and incubated for 48 h at 37°C under aerobic (for Columbia blood agar) or anaerobic conditions. Throat swabs were cultivated on Columbia blood agar, boiled blood agar, and Max Conkey agar. Microbial identification was done by matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF, Bruker, Bremen, Germany) using the direct smear method for samples that were taken in the year 2011. A score above 1.7 was considered valid. Prior to 2011 biochemical identification using standard microbiological procedures such as API- or VITEK-system (Biomerieux, Marcy-l´Etoile, France) was conducted. Negative cultures were kept for a total of 5 days before they were discarded and classified as sterile.

Microorganisms were categorized into two groups:

  • Likely pathogenic microorganisms (group 1): considered as causative pathogen if identified in bile aspirates of patients with cholangitis (e.g. Enterobacteriaceae, Pseudomonas aeruginosa, Bacteroides fragilis, Enterococcus faecalis and faecium, Staphylococcus aureus, Streptococcus anginosus and milleri, Candida spp.)

  • Facultative or unusual pathogens (group 2): microorganisms that rarely cause cholangitis (e.g. Streptococcus viridans, coagulase-negative staphylococci, Enterococcus avium, gallinarum and casseliflavus, Bacillus spp.). Contamination or transient colonization cannot be excluded in these cases.

Antibiotic susceptibility testing was performed according to the CLSI guidelines [12] using the VITEK system (Biomerieux, Marcy-l´Etoile, France).

Clinical data

Clinical Data were extracted from the local health information system (Cerner, North Kansas City, MO) and the local medical information software (Fujifilm, Tokyo, Japan).

Diagnosis of acute cholangitis

Demographic, clinical and biochemical parameters were recorded to assess each patient for the presence of acute cholangitis according to the “Tokyo Guidelines 2018” [11] at the time of ERC.

Endoscopy equipment

Duodenoscopes were from Fujinon (Fujinon Europe, Ltd., Duesseldorf, Germany). Bile was aspirated with bile cannulas (Contour Cannula, Boston Scientific, Natick, MA). In such cases where sphincterotomy was performed, an ultratome (Triple Lumen Sphincterotome, Boston Scientific, Natick, MA) was used. Dilation of stenosis was performed with dilating balloons (Max Force Biliary Balloon dilation, Boston Scientific, Natick, MA).

Double-reprocessing High-Level Disinfection (DHLD) protocol for cleaning duodenoscopes

After each ERC, the duodenoscope’s external surface was wiped and the channels were irrigated with Neodisher EndoClean 10% solution (Dr. Weigert UK Ltd, London, UK). After precleaning, the duodenoscope was immersed in this enzymatic detergent solution and thoroughly cleaned using a single-use, manufacturer recommended brush to remove visible debris from all areas of the duodenoscope (elevator, -recess, -locking mechanism, suction-, air/water-, and instrument-channel port). Manual cleaning was continued until the surface was free of apparent debris. The instrument channels and the suction port were irrigated with the detergent solution and brushed with special brushes (Fujifilm, Tokyo, Japan). Brushes were also used for cleaning of the elevator. Following manual cleaning, the duodenoscope was placed in an automated endoscope reprocessor (Belimed WD430, Zug, Switzerland) for a total cycle time of approximately 60 minutes, using the high-level disinfectant Neodisher EndoSept GA and the high-level detergent Neodisher EndoClean (both Dr. Weigert UK Ltd, London, UK). The entire process of manual cleaning and reprocessing was then repeated to complete the DHLD protocol. All duodenoscopes were dried thoroughly and were stored in ambient air, except those selected for surveillance cultures. There was no forced air drying and duodenoscopes not in use for 7 days underwent repeated HLD. Cleaning and HLD was performed by specially trained staff.

Routine bacteriological surveillance was performed every 3 months by the infection control team of the Division of Hygiene and Medical Microbiology, Medical University of Innsbruck. It included examination of swabs from the working channels and the functionality of the washing machine to sterilize standardized bacterial cultures.

Statistical analysis

Statistical analysis was performed using the chi-square test and association of variables was assessed by Pearson's correlation. A P value < 0.05 was considered statistically significant. The diagnostic properties of microbiological examination of bile aspirates during ERC for the diagnosis of cholangitis were calculated using descriptive statistics. Diagnostic test performance was calculated from the contingency table as indicated in the results section.

In a first step, univariate Cox proportional hazards regression was calculated to identify risk factors predictive for cholangitis in total. In the second step, the subgroups in the univariate analysis were included in a multivariate Cox regression model with stepwise backwards selection. Kaplan-Meier estimates were created and compared using log-rank test and chi-square. Statistical analysis was carried out in IBM SPSS Statistics (IBM, version 24.0, New York City, NY, USA) and GraphPad PRISM 5 (La Jolla, CA).

Ethical consideration

Informed consent was obtained from each patient included in the study. The study protocol conforms to the ethical guidelines of the 1975 Declaration of Helsinki (6th revision, 2008) as reflected in a priori approval by the institution's human research committee. The study protocol was approved by the institutional ethics commission (1100/2022).


Positive microbial bile culture has high sensitivity for cholangitis diagnosis

To assess the microbial composition of bile aspirates during ERC, data from a total of 99 ERCs in 49 patients were included during the study period. Characteristics of these in-hospital patients with indication for ERC, underlying aetiologies, and co-morbidities are listed in Tables 1 and 2. Twenty-nine had one ERC and the remaining 20 patients required multiple ERCs with an actual number of endoscopies ranging from 2 to 7. In 28 patients, endoscopic papillotomy (EPT) was performed and 21 patients underwent previous ERCs with EPT (Tables 1 and 2).

Table 1 Patients´ characteristics and characteristics of ERCs
Table 2 Uni- and multivariate analysis of risk factors for post-ERC cholangitis

A suspected biliary stenosis was the most common indication for ERC (86 of 99 ERCs), including suspected non-anastomotic or anastomotic biliary strictures (NAS/AS) following liver transplantation (OLT), hepatobiliary- and pancreatic-malignancy as well as obstructive gallstone disease (Tables 1 and 2). In 53 ERCs biliary stents were placed during the intervention, of which 40 (75%) were plastic, 6 metal (11%) and in 7 ERCs plastic stents were placed within metal stents (13%). No statistically significant difference, except the level of C-reactive protein (CRP) in laboratory parameters, between patients with or without cholangitis was found (Table 1).

Interestingly, suspected biliary strictures after OLT or choledocholithiasis, as well as markedly elevated CRP levels were significantly more common in the cholangitis than in the non-cholangitis group, but after multivariate analysis adjustment, this difference did no longer reach significance (Table 2). Further analysis of multiple clinical parameters did not show a significant correlation with cholangitis in a univariate/multivariate analysis (Table 2).

Next, the correlation between microbiological test results of bile aspirates during ERC and the clinical diagnosis of cholangitis according to the Tokyo criteria was assessed. Most patients with cholangitis had a positive microbial bile test (91.2%), either with likely pathogenic or facultative pathogenic germs, whereas the first were the leading cause in cholangitis patients (76.5%). However, the same was true in the non-cholangitis group, where 86.2% had a positive microbial bile test with 81.6% likely pathogenic microbes (Table 3).

Table 3 Diagnostic properties of microbiological examination of bile aspirates during ERC for the diagnosis of cholangitis

Any positive microbiological test had 91.2% sensitivity for the clinical and biochemical diagnosis cholangitis, whereas any negative test excluded cholangitis with a negative predictive value of 75%. In contrast, any positive microbial test in bile aspirates had a very low specificity (13.9%) for cholangitis, resulting in a positive predictive value of 35.9% in this real-life patient cohort undergoing ERC (Additional file 1). When bile cultures positive with likely pathogenic microbes (group 1) were compared to facultative pathogenic germs or sterile tests (group 2), the positive predictive value for clinical and biochemical cholangitis was 76.5% and a specificity of 60.0%. Sensitivity was 32.9% (Additional file 1).

Bacteroides fragilis is more common in patients with cholangitis

To evaluate if cholangitis was associated with specific microorganisms in bile aspirates, we compared the microbiological test results of patients with or without cholangitis. No difference was found in Gram positive or Gram negative bacteria as well as in fungi, which were mostly Candida species. Solely, Bacteroides fragilis (p=0.015) was significantly associated with cholangitis (Table 4). The most common microorganisms isolated from bile in the present study were Enterobacteriaceae, especially E. coli, Klebsiella, and Enterococcus species. Bacteroides fragilis and the group of facultative or unusual pathogens were significantly more frequent in patients with cholangitis compared to the non-cholangitis group. To investigate surveillance for pathogens in bile aspirates a validation cohort of patients from 2022 was analysed. The clinical data of the validation cohort are presented in Table 5. There were distinct changes in bile microbiology notable. Samples positive for Escherichia coli (p˂0.01), Enterococcus faecium (p˂0.05), Klebsiella pneumoniae (p˂0.05), Staphylococcus aureus (p˂0.01), Candida albicans (p˂0.05), and Candida dubliensis (p˂0.01), decreased significantly, whereas a significant increase in Enterobacter cloacae (p˂0.05), and Candida glabrata (p˂0.01), could be detected (Fig. 1A).

Table 4 Results from microbiological testing of bile aspirates (all examinations)
Table 5 Patients´ characteristics and characteristics of ERCs of the validation cohort
Fig. 1
figure 1

Microbial analysis of the duodenoscope and the biliary tract. Microbial bile analysis showed significant changes in the microbial composition over 10 years (A). Microbial analysis showed a positive result in 12 duodenoscopes before ERC (B) and these microbes were found in bile aspirates of these patients (C). A longitudinal analysis showed a high persistence rate of transmitted microbes in bile aspirates (D). Patients undergoing ERC with a microbial positive tested duodenoscope had no longer hospital stay (E) or higher cholangitis rates (F). After ERC in 78.8% the microbial analysis of the biliary tract and the used duodenoscopes matched (G). Abbreviations in order of their appearance: ERC – endoscopic retrograde cholangiography, * - p ˂ 0.05, ** - p ˂ 0.01, ns – non significant, = - positive microbiology of duodenoscope and bile acid match, ≠ - positive microbiology of duodenoscope and bile acid did not match

Bile microbiology does match microbial testing of duodenoscopes before ERC

To investigate potential microbial transmission due to contaminated endoscopes, we analyzed irrigation liquid of the endoscopes before ERC. In 12 samples microbes were found in endoscopes (Table 6) and in almost one half (41.7%) of the ERCs with these endoscopes the same microbes were present in the bile of these patients (Fig. 1B). Interestingly, microbes that were found in the irrigation fluid pre ERC always resulted in a positive bile culture for the specific germ (Fig. 1C). Furthermore, in a longitudinal analysis all bacteria (except Acinteobacter baumannii and Klebsiella pneumonia) in one of three cases were present in follow-up ERCs (Fig. 1D). As expected, the microbial analysis of duodenoscopes’ irrigation liquid after ERC (Table 5) did match the microbial bile analysis of these patients in 78.8% of cases (Fig. 1G). But transmission from the duodenoscope to the biliary tract did not result in longer hospital stays (Fig. 1E) or more frequent post ERC cholangitis (Fig. 1F).

Table 6 Results from microbiological testing of duodenoscopes and the oral cavity

Microbial transmission from the oral cavity into the biliary system

We analyzed the oral microbiology of these patients and mostly found fungi in the oral cavity of these 49 patients (Table 6). Candida species were barely significant more often present in the oral microbiota of patient without cholangitis. The finding that identical microbial species are present in throat and in bile samples of the same ERC in 33% of all cases suggests a translocation of oral microbiota to the bile (Fig. 2A). Of the 56 ERCs in patients without cholangitis, but with positive bile cultures, 18 cases presented with identical microbes in throat and bile; - 14 microbes of which are commonly considered as pathogenic if isolated from bile cultures (Fig. 2B). On the other hand, in 14 cholangitis patients identical microbes in throat and bile were found; - 6 microbes of them are considered as non-pathogenic bacteria (Fig. 2C). The bacteria transmitted from the oral cavity to the biliary system are represented in Fig. 2E. Interestingly, Candida albicans was solely transmitted in patients with cholangitis, whereas Candida krusei and Candida tropicalis were only found in patients without cholangitis (Fig. 2E). Except Candida sp most oral pathogens transmitted to the biliary system persisted in a longitudinal analysis of 7 patients (Fig. 2F). A microbial-adapted or -matching antibiotic therapy resulted in a shorter hospital stay in this group (Fig. 2G). Interestingly, in the non-cholangitis group the rate of identical oral and bile microbes was even higher (45%), but did not result in higher cholangitis rates (Fig. 2D) and the supposed transmission from the oral cavity to the biliary tract did not lead to longer hospital stays (Fig. 2H).

Fig. 2
figure 2

Microbial analysis of the oral cavity and the biliary tract. Microbial analysis showed identical microbial species in 33% ERCs (A). Identical microbial analysis in cholangitis and non-cholangitis patients (B). Identical microbes found in throat and bile divided into facultative or unusual pathogens and likely pathogenic microbes (C). Patients undergoing ERC with identical microbial analysis in the oral cavity and bile had no higher cholangitis rates (D). Patients with or without cholangitis had no difference in microbes transmitted to the biliary system (E). In a longitudinal analysis most of these microbes were persistently present in the biliary system (F). Whereas patients with cholangitis and antibiotic therapy matching bile microbiology had a shorter hospital stay (G), the same microbial analysis in the throat and bile did not lead to longer hospital stay (H). Multivariate Cox-Regression analysis identified solely suspected choledocholithiasis as an independent risk factor (I). Abbreviations in order of their appearance: ERC – endoscopic retrograde cholangiography, ns – non significant. =—positive match, ≠—negative match, CRP – c-reactive protein, mg/dl – milligrams/deciliter, HR – hazard ratio, CI – confidence interval

Among all clinical parameters and overlapping microbial signatures in the two compartments analyzed and the pre ERC/post ERC duodenoscopes, four clinical features could be identified as relevant for cholangitis (Tables 1 and 2). These features stayed significant in a univariate Cox analysis (Table 7). Out of these four factors, only suspected choledocholithiasis remained significant in the multivariate regression model for length of hospital stay (Fig. 2I).

Table 7 Univariate analysis for hospital stay in patients with cholangitis


The microbiota and the microbiology of the bile is gaining more and more attention in terms of biliary diseases. ERC is an invasive method and although the endoscopes are reprocessed according to U.S. guidelines and manufacturers’ recommendations for cleaning and HLD process, microbes could still be transferred into the bile, since the device has multiple contacts to germ bearing surfaces during the procedure. And the endoscope might by a biohazard by itself in case of incomplete reprocessing. The key questions of our study were: (1) is there contamination of the bile during ERC, (2) where does it come from, and finally, (3) is it clinically relevant? In our study, we analyzed the oral microbiology, duodenoscopes before and after ERC, and bile from 99 procedures. We could show that the bile is regularly contaminated during ERC by pathogens either from contaminated duodenoscopes or from oral pathogen transfer.

In a recent study in patients with suspected cholangitis 91.8% had positive bile cultures with Enterococcus species (67.6%), Klebsiella spp. (44.5%), E. coli (40.6%), Pseudomonas spp. 52 (7.8%), and anaerobes (9.6%) [13]. Consistent with this report, the most common microorganisms isolated from bile in our study were Enterobacteriaceae, especially E. coli, Klebsiella species, and Enterococcus species. These microorganisms are the most frequent cause of cholangitis [14,15,16]. However, in our cohort, we found these bacteria also in bile samples from the non-cholangitis group and there was a lack of association between the presence of these bacteria and clinical or biochemical cholangitis. The finding that Bacteroides fragilis was the only bacteria that was significantly more frequent in patients with cholangitis supports validity of our data, since Bacteroides fragilis is well known to play a role in biliary infection, especially in elderly patients and patients with previous biliary surgery [15]. The metagenomic analysis has proven invasion and colonization of oral commensals in the gut of patients with cirrhosis [17]. Going along with another study showing the enrichment of oral microbes in the gut of cirrhotic patients with alcohol dependency [18], suggesting that the oral microbiome plays a key role in different liver diseases including biliary obstruction, as shown in an experimental mouse model [19]. In contrast to a previous study [20], biliary candidiasis was associated with positive fungal cultures of buccal smears in our study.

Preventing bile contamination by duodenoscopes is of utmost importance. Recent studies investigated the use of disposable duodenoscopes to prevent biliary infectious complications [21,22,23,24,25,26]. Even when the number of biliary infections could be reduced by excluding microorganisms that cannot be removed during reprocessing the duodenoscope, at least 3.8% of patients that underwent ERC with a disposable duodenoscope presented with microbial contamination, most likely, and in accordance with our data, due to the oral microbiome [27].

Independent risk factors for post-ERC cholangitis like hilar obstruction, age ≥ 60 years, and a history of previous ERC, were evaluated in two studies [28, 29]. Incomplete biliary drainage and factors causing that, like primary sclerosing cholangitis and hilar obstruction, are the main risk factor for post-ERCP cholangitis [30,31,32,33]. In our study we find certain suspected choledocholithiasis, which suggest impeded biliary drainage, as an independent risk factor for the length of hospital stay. These data underline the importance of an unhampered biliary drainage.

In several studies, assessing the contamination rate after duodenoscope reprocessing using either DHLD or ethylene oxid (EtO) sterilization, the reported contamination rate was 9.2%±0.025% [34, 35]. This is in accordance with our findings. While contamination rates of reprocessed duodenoscopes seems to be very high, our data show that microbial translocation from duodenoscopes to bile does not result in longer hospital stays or worse outcome. Microbial analysis of bile compared to analysis from used, non-reprocessed endoscopes after ERC, were highly congruent (78.8%). These facts suggest that duodenoscopes do contaminate the biliary tree but it does not affect clinical outcome.

To date, diverse gastrointestinal diseases were associated with the oral microbiome in a fairly large amount of studies [36]. The bile microbiome and the bacterial composition of the salvia demonstrate a high correlation and a relatively high similarity between the bile microbiome and duodenal microbiota were identified [37, 38]. 13 novel biliary bacteria based on whole-metagenome shotgun sequencing were identified by Shen et al. and 8 of the 13 novel species were human oral microbial taxa [39]. The microbiome of the biliary system and the upper gastrointestinal tract can be modulated by the oral microbiota directly or indirectly [40]. Oral bacteria participate in the pathogenesis of gallstone diseases [40], although a clear understanding of the mechanisms of their influence on the cholelithogenesis is lacking [41]. In patients with gall stone disease the most common inhabitants of the digestive tract are Proteobacteria, Firmicutes, Bacteroidetes, Actinobacteria, Fusobacteria, as well as Synergistetes and TM7 [42]. Interestingly Enterococci genera are regularly found in the oral microbiome leading to oral disease e.g. caries or endodontic infections [43]. Two Enterobacteriaceae genera (E. coli, Klebsiella spp.) and Enterococcus faecium were detected in the majority of bile samples and Bacteroides fragilis, belonging to the Bacteroidetes phyla, was associated with cholangitis in our study. Furthermore, Enberobacteriaceae genera were abundant in the oral cavity as well as in the gut microbiome of patients with colitis, suggesting that the biliary tree might also be contaminated from the oral cavity [44]. Our data are supportive for this concept: identical microbial species were present in throat and in bile samples of the same ERC in 33% of all cases. Although this pathogen transfer did not lead to more frequent cholangitis or worse clinical outcome, we assumed that the microbial analysis of bile aspirates might influence the post-ERC treatment and the duration of the hospital stay. An antibiotic treatment adapted to the microbial analysis of bile aspirates shortened length of hospital stay.

Important limitations of this study are the small number of patients and the heterogenic patient population. It may be another potential limitation, that there is no reference method for biliary sampling in our setting (e.g., via percutaneous transhepatic biliary drainage). Furthermore, our findings from this analysis of real-life data are not universally applicable but reflect treatment with mainly interventional ERC of contemporary patient populations at a tertiary referral center.


In conclusion, this retrospective study shows that contamination of the bile with the oral microbiome via ERC is likely, but mostly harmless. Aspiration and microbiological sampling of bile is feasible, but interpretation of the result remains challenging. Further, more powerful studies are needed.

Availability of data and materials

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.



Anastomotic biliary stricture


Bacteroides Bile Esculin


C-reactive protein


Distal biliary strictures


Double-reprocessing High-Level Disinfection


Endoscopic retrograde cholangiography


Endoscopic papillotomy


High-Level Disinfection


Non-anastomotic biliary stricture


Orthothopic liver transplant


  1. Nakai Y, Isayama H, Wang HP, Rerknimitr R, Khor C, Yasuda I, Kogure H, Moon JH, Lau J, Lakhtakia S, et al. International consensus statements for endoscopic management of distal biliary stricture. J Gastroenterol Hepatol. 2020;35(6):967–79.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Zhu Y, Tu J, Zhao Y, Jing J, Dong Z, Pan W. Association of timing of biliary drainage with clinical outcomes in severe acute cholangitis: a retrospective cohort study. Int J Gen Med. 2021;14:2953–63.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Manes G, Paspatis G, Aabakken L, Anderloni A, Arvanitakis M, Ah-Soune P, Barthet M, Domagk D, Dumonceau JM, Gigot JF, et al. Endoscopic management of common bile duct stones: European Society of Gastrointestinal Endoscopy (ESGE) guideline. Endoscopy. 2019;51(5):472–91.

    Article  PubMed  Google Scholar 

  4. Tan M. Schaffalitzky de Muckadell OB, Laursen SB: Association between early ERCP and mortality in patients with acute cholangitis. Gastrointest Endosc. 2018;87(1):185–92.

    Article  PubMed  Google Scholar 

  5. Visrodia KH, Ofstead CL, Yellin HL, Wetzler HP, Tosh PK, Baron TH. The use of rapid indicators for the detection of organic residues on clinically used gastrointestinal endoscopes with and without visually apparent debris. Infect Control Hosp Epidemiol. 2014;35(8):987–94.

    Article  PubMed  Google Scholar 

  6. Ribeiro MM, de Oliveira AC, Ribeiro SM, Watanabe E, de Resende Stoianoff MA, Ferreira JA. Effectiveness of flexible gastrointestinal endoscope reprocessing. Infect Control Hosp Epidemiol. 2013;34(3):309–12.

    Article  PubMed  Google Scholar 

  7. Brandabur JJ, Leggett JE, Wang L, Bartles RL, Baxter L, Diaz GA, Grunkemeier GL, Hove S, Oethinger M. Surveillance of guideline practices for duodenoscope and linear echoendoscope reprocessing in a large healthcare system. Gastrointest Endosc. 2016;84(3):392-399.e393.

    Article  PubMed  Google Scholar 

  8. Rubin ZA, Kim S, Thaker AM, Muthusamy VR. Safely reprocessing duodenoscopes: current evidence and future directions. Lancet Gastroenterol Hepatol. 2018;3(7):499–508.

    Article  PubMed  Google Scholar 

  9. Andriulli A, Loperfido S, Napolitano G, Niro G, Valvano MR, Spirito F, Pilotto A, Forlano R. Incidence rates of post-ERCP complications: a systematic survey of prospective studies. Am J Gastroenterol. 2007;102(8):1781–8.

    Article  PubMed  Google Scholar 

  10. Bilbao MK, Dotter CT, Lee TG, Katon RM. Complications of endoscopic retrograde cholangiopancreatography (ERCP). A study of 10,000 cases. Gastroenterology. 1976;70(3):314–20.

    Article  CAS  PubMed  Google Scholar 

  11. Kiriyama S, Kozaka K, Takada T, Strasberg SM, Pitt HA, Gabata T, Hata J, Liau KH, Miura F, Horiguchi A, et al. Tokyo Guidelines 2018: diagnostic criteria and severity grading of acute cholangitis (with videos). J Hepatobiliary Pancreat Sci. 2018;25(1):17–30.

    Article  PubMed  Google Scholar 

  12. Laboratory NCfC, Standards: Performance standards for antimicrobial disk susceptibility tests. Approved standard M2-A6. Villanova: NCCLS; 2002.

  13. Gromski MA, Gutta A, Lehman GA, Tong Y, Fogel EL, Watkins JL, Easler JJ, Bick B, McHenry L, Beeler C, et al. Microbiology of bile aspirates obtained at ERCP in patients with suspected acute cholangitis. Endoscopy. 2022;54(11):1045–52.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Kullman E, Borch K, Lindstrom E, Ansehn S, Ihse I, Anderberg B. Bacteremia following diagnostic and therapeutic ERCP. Gastrointest Endosc. 1992;38(4):444–9.

    Article  CAS  PubMed  Google Scholar 

  15. Negm AA, Schott A, Vonberg RP, Weismueller TJ, Schneider AS, Kubicka S, Strassburg CP, Manns MP, Suerbaum S, Wedemeyer J, et al. Routine bile collection for microbiological analysis during cholangiography and its impact on the management of cholangitis. Gastrointest Endosc. 2010;72(2):284–91.

    Article  PubMed  Google Scholar 

  16. Rupp C, Bode K, Weiss KH, Rudolph G, Bergemann J, Kloeters-Plachky P, Chahoud F, Stremmel W, Gotthardt DN, Sauer P. Microbiological assessment of bile and corresponding antibiotic treatment: a strobe-compliant observational study of 1401 endoscopic retrograde cholangiographies. Medicine (Baltimore). 2016;95(10): e2390.

    Article  CAS  PubMed  Google Scholar 

  17. Qin N, Yang F, Li A, Prifti E, Chen Y, Shao L, Guo J, Le Chatelier E, Yao J, Wu L, et al. Alterations of the human gut microbiome in liver cirrhosis. Nature. 2014;513(7516):59–64.

    Article  CAS  PubMed  Google Scholar 

  18. Dubinkina VB, Tyakht AV, Odintsova VY, Yarygin KS, Kovarsky BA, Pavlenko AV, Ischenko DS, Popenko AS, Alexeev DG, Taraskina AY, et al. Links of gut microbiota composition with alcohol dependence syndrome and alcoholic liver disease. Microbiome. 2017;5(1):141.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Wu T, Zhang Z, Liu B, Hou D, Liang Y, Zhang J, Shi P. Gut microbiota dysbiosis and bacterial community assembly associated with cholesterol gallstones in large-scale study. BMC Genomics. 2013;14:669.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Lenz P, Conrad B, Kucharzik T, Hilker E, Fegeler W, Ullerich H, Heinecke A, Domschke W, Domagk D. Prevalence, associations, and trends of biliary-tract candidiasis: a prospective observational study. Gastrointest Endosc. 2009;70(3):480–7.

    Article  PubMed  Google Scholar 

  21. Forbes N, Elmunzer BJ, Allain T, Chau M, Koury HF, Bass S, Belletrutti PJ, Cole MJ, Gonzalez-Moreno E, Kayal A, et al. Infection control in ERCP using a duodenoscope with a disposable cap (ICECAP): rationale for and design of a randomized controlled trial. BMC Gastroenterol. 2020;20(1):64.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Trindade AJ, Copland A, Bhatt A, Bucobo JC, Chandrasekhara V, Krishnan K, Parsi MA, Kumta N, Law R, Pannala R, et al. Single-use duodenoscopes and duodenoscopes with disposable end caps. Gastrointest Endosc. 2021;93(5):997–1005.

    Article  PubMed  Google Scholar 

  23. Muthusamy VR, Bruno MJ, Kozarek RA, Petersen BT, Pleskow DK, Sejpal DV, Slivka A, Peetermans JA, Rousseau MJ, Tirrell GP, et al. Clinical evaluation of a single-use duodenoscope for endoscopic retrograde cholangiopancreatography. Clin Gastroenterol Hepatol. 2020;18(9):2108-2117.e2103.

    Article  PubMed  Google Scholar 

  24. Napoléon B, Gonzalez JM, Grandval P, Lisotti A, Laquière AE, Boustière C, Barthet M, Prat F, Ponchon T, Donatelli G, et al. Evaluation of the performances of a single-use duodenoscope: Prospective multi-center national study. Dig Endosc. 2022;34(1):215–21.

    Article  PubMed  Google Scholar 

  25. Bang JY, Hawes R, Varadarajulu S. Equivalent performance of single-use and reusable duodenoscopes in a randomised trial. Gut. 2021;70(5):838–44.

    Article  CAS  PubMed  Google Scholar 

  26. Slivka A, Ross AS, Sejpal DV, Petersen BT, Bruno MJ, Pleskow DK, Muthusamy VR, Chennat JS, Krishnamoorthi R, Lee C, et al. Single-use duodenoscope for ERCP performed by endoscopists with a range of experience in procedures of variable complexity. Gastrointest Endosc. 2021;94(6):1046–55.

    Article  PubMed  Google Scholar 

  27. Forbes N, Elmunzer BJ, Allain T, Parkins MD, Sheth PM, Waddell BJ, Du K, Douchant K, Oladipo O, Saleem A, et al. Effect of disposable elevator cap duodenoscopes on persistent microbial contamination and technical performance of endoscopic retrograde cholangiopancreatography: the ICECAP Randomized Clinical Trial. JAMA Intern Med. 2023;183(3):191–200.

  28. Loperfido S, Angelini G, Benedetti G, Chilovi F, Costan F, De Berardinis F, De Bernardin M, Ederle A, Fina P, Fratton A. Major early complications from diagnostic and therapeutic ERCP: a prospective multicenter study. Gastrointest Endosc. 1998;48(1):1–10.

    Article  CAS  PubMed  Google Scholar 

  29. Chen M, Wang L, Wang Y, Wei W, Yao YL, Ling TS, Shen YH, Zou XP. Risk factor analysis of post-ERCP cholangitis: a single-center experience. Hepatobil Pancreat Dis Int. 2018;17(1):55–8.

    Article  Google Scholar 

  30. Lee JG, Lee CE. Infection after ERCP, and antibiotic prophylaxis: a sequential quality-improvement approach over 11 years. Gastrointest Endosc. 2008;67(3):476–7.

    Article  PubMed  Google Scholar 

  31. Navaneethan U, Jegadeesan R, Nayak S, Lourdusamy V, Sanaka MR, Vargo JJ, Parsi MA. ERCP-related adverse events in patients with primary sclerosing cholangitis. Gastrointest Endosc. 2015;81(2):410–9.

    Article  PubMed  Google Scholar 

  32. Motte S, Deviere J, Dumonceau JM, Serruys E, Thys JP, Cremer M. Risk factors for septicemia following endoscopic biliary stenting. Gastroenterology. 1991;101(5):1374–81.

    Article  CAS  PubMed  Google Scholar 

  33. Thiruvengadam NR, Kouanda A, Kalluri A, Schaubel D, Saumoy M, Forde K, Song J, Faggen A, Davis BG, Onwugaje KC, et al. A prospective cohort study evaluating PAN-PROMISE, a patient-reported Outcome Measure to Detect Post-ERCP Morbidity. Clin Gastroenterol Hepatol. 2022;S1542-3565(22):830-8.

  34. Larsen S, Russell RV, Ockert LK, Spanos S, Travis HS, Ehlers LH, Mærkedahl A. Rate and impact of duodenoscope contamination: a systematic review and meta-analysis. EClinicalMedicine. 2020;25: 100451.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Bomman S, Ashat M, Nagra N, Jayaraj M, Chandra S, Kozarek RA, Ross A, Krishnamoorthi R. Contamination rates in duodenoscopes reprocessed using enhanced surveillance and reprocessing techniques: a systematic review and meta-analysis. Clin Endosc. 2022;55(1):33–40.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Gao L, Xu T, Huang G, Jiang S, Gu Y, Chen F. Oral microbiomes: more and more importance in oral cavity and whole body. Protein Cell. 2018;9(5):488–500.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Hu H, Shao W, Liu Q, Liu N, Wang Q, Xu J, Zhang X, Weng Z, Lu Q, Jiao L, et al. Gut microbiota promotes cholesterol gallstone formation by modulating bile acid composition and biliary cholesterol secretion. Nat Commun. 2022;13(1):252.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Grigor'eva IN, Romanova TI. Gallstone disease and microbiome. Microorganisms. 2020;8(6):835.

  39. Shen H, Ye F, Xie L, Yang J, Li Z, Xu P, Meng F, Li L, Chen Y, Bo X, et al. Metagenomic sequencing of bile from gallstone patients to identify different microbial community patterns and novel biliary bacteria. Sci Rep. 2015;5:17450.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Walker MY, Pratap S, Southerland JH, Farmer-Dixon CM, Lakshmyya K, Gangula PR. Role of oral and gut microbiome in nitric oxide-mediated colon motility. Nitric Oxide. 2018;73:81–8.

    Article  CAS  PubMed  Google Scholar 

  41. Bhandari S, Reddy M, Shahzad G. Association between oral hygiene and ultrasound-confirmed gallstone disease in US population. Eur J Gastroenterol Hepatol. 2017;29(7):861–2.

    Article  PubMed  Google Scholar 

  42. Ye F, Shen H, Li Z, Meng F, Li L, Yang J, Chen Y, Bo X, Zhang X, Ni M. Influence of the biliary system on biliary bacteria revealed by bacterial communities of the human biliary and upper digestive tracts. PLoS ONE. 2016;11(3): e0150519.

    Article  PubMed  PubMed Central  Google Scholar 

  43. Komiyama EY, Lepesqueur LS, Yassuda CG, Samaranayake LP, Parahitiyawa NB, Balducci I, Koga-Ito CY. Enterococcus species in the oral cavity: prevalence, virulence factors and antimicrobial susceptibility. PLoS ONE. 2016;11(9): e0163001.

    Article  PubMed  PubMed Central  Google Scholar 

  44. Kitamoto S, Nagao-Kitamoto H, Jiao Y, Gillilland MG, Hayashi A, Imai J, Sugihara K, Miyoshi M, Brazil JC, Kuffa P, et al. The intermucosal connection between the mouth and gut in commensal pathobiont-driven colitis. Cell. 2020;182(2):447-462.e414.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references


Not applicable.


HZ gratefully acknowledges the financial support by the Austrian Federal Ministry for Digital and Economic Affairs, the National Foundation for Research, Technology and Development and the Christian Doppler Research Association. HT is supported by the excellence initiative VASCage (Centre for Promoting Vascular Health in the Ageing Community), an R&D K-Centre (COMET program - Competence Centers for Excellent Technologies) funded by the Austrian Ministry for Transport, Innovation and Technology, the Austrian Ministry for Digital and Economic Affairs and the federal states Tyrol, Salzburg and Vienna.

Author information

Authors and Affiliations



ME and HZ designed the project and wrote the paper. HS and IG collected human data. RA and ME verified the analytical methods and analysed the data. HS was involved in patient´s recruitment. RG analysed the microbiological datasets. HZ and HT provided critical feedback and contributed to data analysis. RA, ME, and HT contributed to the manuscript preparation along with HZ. The author(s) read and approved the final manuscript.

Corresponding author

Correspondence to Heinz Zoller.

Ethics declarations

Ethics approval and consent to participate

Informed consent was obtained from each patient included in the study. The study protocol conforms to the ethical guidelines of the 1975 Declaration of Helsinki (6th revision, 2008) as reflected in a priori approval by the institution's human research committee. The study/experimental protocol was approved by the ethics commission of the Medical University of Innsbruck (Protocol Number: 1100/2022).

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Additional file 1:

 Supplementary Table 1.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Effenberger, M., Al-Zoairy, R., Gstir, R. et al. Transmission of oral microbiota to the biliary tract during endoscopic retrograde cholangiography. BMC Gastroenterol 23, 103 (2023).

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: